Publications

Similar articles

Expansion of effector regulatory T cells in steroid responders of severe alcohol-associated hepatitis.

Kang MW, Lee SK, Jang EJ, Park JG, Seo DH, Han JW, Yoo JS, Kwon JH, Nam SW, Jang JW, Choi JY, Yoon SK, Sung PS.Liver Transpl. 2024 Sep 1;30(9):877-886. doi: 10.1097/LVT.0000000000000378. Epub 2024 Apr 17.PMID: 38809243

Alcoholic hepatitis--a clinical and pathological study of 142 cases.

Mihas AA, Doos WG, Spenney JG.J Chronic Dis. 1978;31(6-7):461-72. doi: 10.1016/0021-9681(78)90010-3.PMID: 309472No abstract available.

Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids.

Taïeb J, Mathurin P, Elbim C, Cluzel P, Arce-Vicioso M, Bernard B, Opolon P, Gougerot-Pocidalo MA, Poynard T, Chollet-Martin S.J Hepatol. 2000 Apr;32(4):579-86. doi: 10.1016/s0168-8278(00)80219-6.PMID: 10782906

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

Mathurin P, Mendenhall CL, Carithers RL Jr, Ramond MJ, Maddrey WC, Garstide P, Rueff B, Naveau S, Chaput JC, Poynard T.J Hepatol. 2002 Apr;36(4):480-7. doi: 10.1016/s0168-8278(01)00289-6.PMID: 11943418

Glucocorticosteroids for people with alcoholic hepatitis.

Pavlov CS, Varganova DL, Casazza G, Tsochatzis E, Nikolova D, Gluud C.Cochrane Database Syst Rev. 2017 Nov 2;11(11):CD001511. doi: 10.1002/14651858.CD001511.pub3.Update in:Cochrane Database Syst Rev. 2019 Apr 09;4:CD001511. doi: 10.1002/14651858.CD001511.pub4.PMID: 29096421Free PMC article.

See all similar articles